FOXP3 and tuberculosis: Therefore, the COX inhibitor indomethacin could initiate an anti-TB chemotherapy effect by significantly downregulating M.tb-specific FOXP3+ T regulatory cells, reducing cytokine responses and Th1 cell proliferation in patients with active TB [15].